Inamed GmbH Report issue

For profit Phase 1 Phase 2
Founded: Santa Barbara CA United States (1974)
Status: Acquired by Allergan PLC (2015) (2006) → now AbbVie (2019)

Organization Overview

First Clinical Trial
2010
NCT01176747
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Inamed Research GmbH & Co. KG

Active Ingredients

Drugs in Phase 2 Trials (2)

beclomethasone (vanceril) (1 trial)

formoterol (foradil) (1 trial)

Drugs in Phase 1 Trials (1)

tobramycin (nebcin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cystic Fibrosis (Phase 1)

Pulmonary Disease, Chronic Obstructive (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3